Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dorzolamide hydrochloride (MK507 hydrochloride) is the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 37.00 | |
10 mg | In stock | $ 50.00 | |
25 mg | In stock | $ 61.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 153.00 | |
200 mg | In stock | $ 227.00 | |
500 mg | In stock | $ 383.00 |
Description | Dorzolamide hydrochloride (MK507 hydrochloride) is the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. |
Targets&IC50 | CA IV:31 nM(Ki), CA II:1.9 nM(Ki), CA I:6000 nM(Ki) |
In vitro | In rabbits, Dorzolamide hydrochloride significantly reduces intraocular pressure (IOP) and is effective at night as well. Dorzolamide substantially decreases IOP in glaucoma-afflicted monkeys by 22%, 30%, and 37%. The combination of Dorzolamide (administered topically to the eye for 1 to 5 days) and oral methazolamide (administered from day 3 to day 5) significantly lower IOP, with this effect persisting on days 1, 3, and 5. Compared to the regimen of twice-daily oral methazolamide and 2% Dorzolamide, applying Dorzolamide (2%) topically three times a day achieves a similar reduction in IOP. |
In vivo | Dorzolamide induces dilation of retinal blood vessels through three distinct mechanisms that directly cause precontraction, independent of extracellular pH changes. It acts as a potent inhibitor of carbonic anhydrase (CA) II, penetrating the sclera and cornea to reach the ciliary processes and reduce the formation of HCO3 and aqueous humor. |
Synonyms | MK507 hydrochloride, L671152 hydrochloride, MK-507 (L-671152) HCl, Dorzolamide HCl |
Molecular Weight | 360.9 |
Formula | C10H17ClN2O4S3 |
CAS No. | 130693-82-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 13.3mg/ml(36.9mM)
DMSO: 1mg/ml(2.77mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dorzolamide hydrochloride 130693-82-2 Metabolism Carbonic Anhydrase anti-tumor Inhibitor CA-II Carbonate dehydratase MK507 hydrochloride inhibit L671152 hydrochloride MK 507 solid L671152 EAC MK 507 Hydrochloride MK-507 L-671152 Hydrochloride L-671152 MK507 Hydrochloride MK-507 (L-671152) HCl Dorzolamide tumor MK-507 Hydrochloride L671152 Hydrochloride L 671152 Hydrochloride L 671152 Dorzolamide HCl Dorzolamide Hydrochloride MK507 inhibitor